iShares Biotechnology ETF Holdings
IBB was created on 2001-02-05 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 5129.9m in AUM and 257 holdings. IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.
Last Updated: 3 days, 6 hours ago
Last reported holdings - iShares Biotechnology ETF
| Ticker | Name | Est. Value |
|---|---|---|
|
VRTX
|
VERTEX PHARMACEUTICALS INC | $502.1 million |
|
GILD
|
GILEAD SCIENCES INC | $451.4 million |
|
AMGN
|
AMGEN INC | $445.9 million |
|
REGN
|
REGENERON PHARMACEUTICALS INC | $406.4 million |
|
ALNY
|
ALNYLAM PHARMACEUTICALS INC | $199.1 million |
|
IQV
|
IQVIA HOLDINGS INC | $165.2 million |
|
ARGX
|
ARGENX SE ADR | $165.2 million |
|
MTD
|
METTLER TOLEDO INC | $138.0 million |
|
WAT
|
WATERS CORP | $127.2 million |
|
NTRA
|
NATERA INC | $123.4 million |
|
BIIB
|
BIOGEN INC | $109.5 million |
|
BNTX
|
BIONTECH SE ADR | $107.1 million |
|
ONC
|
BEIGENE ADS REPRESENTING LTD | $86.5 million |
|
UTHR
|
UNITED THERAPEUTICS CORP | $82.6 million |
|
INSM
|
INSMED INC | $77.9 million |
|
ILMN
|
ILLUMINA INC | $76.8 million |
|
BMRN
|
BIOMARIN PHARMACEUTICAL INC | $74.9 million |
|
INCY
|
INCYTE CORP | $71.6 million |
|
EXEL
|
EXELIXIS INC | $66.1 million |
|
NBIX
|
NEUROCRINE BIOSCIENCES INC | $65.1 million |
|
GMAB
|
GENMAB SPONSORED ADR | $60.1 million |
|
MRNA
|
MODERNA INC | $59.2 million |
|
TECH
|
BIO TECHNE CORP | $49.6 million |
|
RGEN
|
REPLIGEN CORP | $47.9 million |
|
MEDP
|
MEDPACE HOLDINGS INC | $47.0 million |
|
HALO
|
HALOZYME THERAPEUTICS INC | $46.6 million |
|
ASND
|
ASCENDIS PHARMA ADR REPRESENTING | $43.7 million |
|
RVMD
|
REVOLUTION MEDICINES INC | $42.3 million |
|
MDGL
|
MADRIGAL PHARMACEUTICALS INC | $38.9 million |
|
CRL
|
CHARLES RIVER LABORATORIES INTERNA | $36.7 million |
|
ADMA
|
ADMA BIOLOGICS INC | $35.2 million |
|
BPMC
|
BLUEPRINT MEDICINES CORP | $35.0 million |
|
SRPT
|
SAREPTA THERAPEUTICS INC | $34.9 million |
|
BBIO
|
BRIDGEBIO PHARMA INC | $33.8 million |
|
ROIV
|
ROIVANT SCIENCES LTD | $31.2 million |
|
CYTK
|
CYTOKINETICS INC | $30.0 million |
|
IONS
|
IONIS PHARMACEUTICALS INC | $29.0 million |
|
ALKS
|
ALKERMES | $27.9 million |
|
LEGN
|
LEGEND BIOTECH ADR REP CORP | $27.8 million |
|
AXSM
|
AXSOME THERAPEUTICS INC | $27.1 million |
|
TEM
|
TEMPUS AI INC CLASS A | $26.4 million |
|
KRYS
|
KRYSTAL BIOTECH INC | $26.3 million |
|
PCVX
|
VAXCYTE INC | $26.0 million |
|
BRKR
|
BRUKER CORP | $25.8 million |
|
PTCT
|
PTC THERAPEUTICS INC | $24.2 million |
|
RYTM
|
RHYTHM PHARMACEUTICALS INC | $22.8 million |
|
VRNA
|
VERONA PHARMA ADR PLC | $22.1 million |
|
RNA
|
AVIDITY BIOSCIENCES INC | $21.9 million |
|
NUVL
|
NUVALENT INC CLASS A | $21.0 million |
|
RARE
|
ULTRAGENYX PHARMACEUTICAL INC | $20.7 million |
|
SWTX
|
SPRINGWORKS THERAPEUTICS INC | $20.4 million |
|
CRSP
|
CRISPR THERAPEUTICS AG | $19.7 million |
|
CRNX
|
CRINETICS PHARMACEUTICALS INC | $18.1 million |
|
AKRO
|
AKERO THERAPEUTICS INC | $17.7 million |
|
XENE
|
XENON PHARMACEUTICALS INC | $17.7 million |
|
MRUS
|
MERUS NV | $17.5 million |
|
SMMT
|
SUMMIT THERAPEUTICS INC | $17.5 million |
|
ACLX
|
ARCELLX INC | $16.4 million |
|
PTGX
|
PROTAGONIST THERAPEUTICS INC | $16.2 million |
|
ZLAB
|
ZAI LABORATORY ADR REPRESENTING LT | $15.5 million |
|
ACAD
|
ACADIA PHARMACEUTICALS INC | $15.3 million |
|
VCYT
|
VERACYTE INC | $15.3 million |
|
SRRK
|
SCHOLAR ROCK HOLDING CORP | $14.6 million |
|
TWST
|
TWIST BIOSCIENCE CORP | $14.2 million |
|
FOLD
|
AMICUS THERAPEUTICS INC | $13.8 million |
|
DNLI
|
DENALI THERAPEUTICS INC | $12.9 million |
|
BHVN
|
BIOHAVEN LTD | $12.1 million |
|
VCEL
|
VERICEL CORP | $12.1 million |
|
APLS
|
APELLIS PHARMACEUTICALS INC | $11.7 million |
|
KYMR
|
KYMERA THERAPEUTICS INC | $11.5 million |
|
NVCR
|
NOVOCURE LTD | $11.4 million |
|
BEAM
|
BEAM THERAPEUTICS INC | $11.0 million |
|
RXRX
|
RECURSION PHARMACEUTICALS INC CLAS | $10.9 million |
|
TVTX
|
TRAVERE THERAPEUTICS INC | $10.7 million |
|
TARS
|
TARSUS PHARMACEUTICALS INC | $10.4 million |
|
BCRX
|
BIOCRYST PHARMACEUTICALS INC | $10.3 million |
|
AGIO
|
AGIOS PHARMACEUTICALS INC | $10.3 million |
|
MIRM
|
MIRUM PHARMACEUTICALS INC | $10.1 million |
|
IDYA
|
IDEAYA BIOSCIENCES INC | $10.1 million |
|
JANX
|
JANUX THERAPEUTICS INC | $9.8 million |
|
ARQT
|
ARCUTIS BIOTHERAPEUTICS INC | $9.6 million |
|
ARWR
|
ARROWHEAD PHARMACEUTICALS INC | $8.9 million |
|
MNKD
|
MANNKIND CORP | $8.8 million |
|
APGE
|
APOGEE THERAPEUTICS INC | $8.6 million |
|
GRFS
|
GRIFOLS ADR REPRESENTING ONE NON-V | $8.5 million |
|
DVAX
|
DYNAVAX TECHNOLOGIES CORP | $8.4 million |
|
CGON
|
CG ONCOLOGY INC | $8.1 million |
|
VERA
|
VERA THERAPEUTICS INC CLASS A | $7.2 million |
|
SNDX
|
SYNDAX PHARMACEUTICALS INC | $7.1 million |
|
ADPT
|
ADAPTIVE BIOTECHNOLOGIES CORP | $7.0 million |
|
IMVT
|
IMMUNOVANT INC | $6.7 million |
|
STVN
|
STEVANATO GROUP | $6.7 million |
|
EWTX
|
EDGEWISE THERAPEUTICS INC | $6.6 million |
|
GRAL
|
GRAIL INC | $6.5 million |
|
ETNB
|
89BIO INC | $6.5 million |
|
MESO
|
MESOBLAST ADR REPRESENTING LTD | $6.4 million |
|
EVO
|
EVOTEC SE SPONSORED ADR | $6.4 million |
|
NAMS
|
NEWAMSTERDAM PHARMA NV | $6.4 million |
|
AUPH
|
AURINIA PHARMACEUTICALS INC | $6.2 million |
|
NVAX
|
NOVAVAX INC | $6.2 million |
|
IRON
|
DISC MEDICINE INC | $6.2 million |
|
IOVA
|
IOVANCE BIOTHERAPEUTICS INC | $6.1 million |
|
DYN
|
DYNE THERAPEUTICS INC | $6.0 million |
|
IMCR
|
IMMUNOCORE HOLDINGS ADR PLC | $5.9 million |
|
CDNA
|
CAREDX INC | $5.8 million |
|
XTSLA
|
BLK CSH FND TREASURY SL AGENCY | $5.7 million |
|
GPCR
|
STRUCTURE THERAPEUTICS ADR INC | $5.7 million |
|
GLPG
|
GALAPAGOS ADR REPRESENTING NV | $5.6 million |
|
ALVO
|
ALVOTECH SA | $5.6 million |
|
TXG
|
10X GENOMICS INC CLASS A | $5.4 million |
|
ZYME
|
ZYMEWORKS INC | $5.4 million |
|
NRIX
|
NURIX THERAPEUTICS INC | $5.4 million |
|
GERN
|
GERON CORP | $5.3 million |
|
WVE
|
WAVE LIFE SCIENCES LTD | $5.3 million |
|
NTLA
|
INTELLIA THERAPEUTICS INC | $5.2 million |
|
AVXL
|
ANAVEX LIFE SCIENCES CORP | $5.0 million |
|
CNTA
|
CENTESSA PHARMACEUTICALS AMERICAN | $4.8 million |
|
SYRE
|
SPYRE THERAPEUTICS INC | $4.7 million |
|
SPRY
|
ARS PHARMACEUTICALS INC | $4.6 million |
|
RCKT
|
ROCKET PHARMACEUTICALS INC | $4.5 million |
|
XNCR
|
XENCOR INC | $4.4 million |
|
QURE
|
UNIQURE NV | $4.2 million |
|
MYGN
|
MYRIAD GENETICS INC | $4.1 million |
|
PRAX
|
PRAXIS PRECISION MEDICINES INC | $4.0 million |
|
LENZ
|
LENZ THERAPEUTICS INC | $3.9 million |
|
ANAB
|
ANAPTYSBIO INC | $3.8 million |
|
ELVN
|
ENLIVEN THERAPEUTICS INC | $3.8 million |
|
ABCL
|
ABCELLERA BIOLOGICS INC | $3.7 million |
|
DAWN
|
DAY ONE BIOPHARMACEUTICALS INC | $3.6 million |
|
REPL
|
REPLIMUNE GROUP INC | $3.6 million |
|
CSTL
|
CASTLE BIOSCIENCES INC | $3.5 million |
|
ARVN
|
ARVINAS INC | $3.5 million |
|
FTRE
|
FORTREA HOLDINGS INC | $3.4 million |
|
CRMD
|
CORMEDIX INC | $3.4 million |
|
VIR
|
VIR BIOTECHNOLOGY INC | $3.4 million |
|
MLYS
|
MINERALYS THERAPEUTICS INC | $3.2 million |
|
KALV
|
KALVISTA PHARMACEUTICALS INC | $3.2 million |
|
NUVB
|
NUVATION BIO INC CLASS A | $3.1 million |
|
ABUS
|
ARBUTUS BIOPHARMA CORP | $3.1 million |
|
RCUS
|
ARCUS BIOSCIENCES INC | $3.1 million |
|
KROS
|
KEROS THERAPEUTICS INC | $3.0 million |
|
KURA
|
KURA ONCOLOGY INC | $3.0 million |
|
COGT
|
COGENT BIOSCIENCES INC | $2.9 million |
|
CTKB
|
CYTEK BIOSCIENCES INC | $2.9 million |
|
TBPH
|
THERAVANCE BIOPHARMA INC | $2.8 million |
|
OPK
|
OPKO HEALTH INC | $2.8 million |
|
LAB
|
STANDARD BIOTOOLS INC | $2.7 million |
|
SAGE
|
SAGE THERAPEUTICS INC | $2.7 million |
|
RLAY
|
RELAY THERAPEUTICS INC | $2.7 million |
|
RGNX
|
REGENXBIO INC | $2.6 million |
|
PRTA
|
PROTHENA PLC | $2.6 million |
|
AVBP
|
ARRIVENT BIOPHARMA INC | $2.6 million |
|
URGN
|
UROGEN PHARMA LTD | $2.5 million |
|
STOK
|
STOKE THERAPEUTICS INC | $2.5 million |
|
ALT
|
ALTIMMUNE INC | $2.5 million |
|
ZVRA
|
ZEVRA THERAPEUTICS INC | $2.4 million |
|
VERV
|
VERVE THERAPEUTICS INC | $2.4 million |
|
MGTX
|
MEIRAGTX HOLDINGS PLC | $2.3 million |
|
FLGT
|
FULGENT GENETICS INC | $2.3 million |
|
TRVI
|
TREVI THERAPEUTICS INC | $2.2 million |
|
RIGL
|
RIGEL PHARMACEUTICALS INC | $2.1 million |
|
ABSI
|
ABSCI CORP | $2.1 million |
|
TYRA
|
TYRA BIOSCIENCES INC | $2.1 million |
|
5CV.DE
|
CUREVAC NV | $2.1 million |
|
ARCT
|
ARCTURUS THERAPEUTICS HOLDINGS INC | $1.9 million |
|
AMLX
|
AMYLYX PHARMACEUTICALS INC | $1.9 million |
|
ORKA
|
ORUKA THERAPEUTICS INC | $1.9 million |
|
EBS
|
EMERGENT BIOSOLUTIONS INC | $1.9 million |
|
DNA
|
GINKGO BIOWORKS HOLDINGS INC CLASS | $1.8 million |
|
SVRA
|
SAVARA INC | $1.8 million |
|
MXCT
|
MAXCYTE INC | $1.8 million |
|
TSHA
|
TAYSHA GENE THERAPIES INC | $1.8 million |
|
PACB
|
PACIFIC BIOSCIENCES OF CALIFORNIA | $1.7 million |
|
CGEM
|
CULLINAN THERAPEUTICS INC | $1.7 million |
|
TRML
|
TOURMALINE BIO INC | $1.7 million |
|
OLMA
|
OLEMA PHARMACEUTICALS INC | $1.7 million |
|
AURA
|
AURA BIOSCIENCES INC | $1.6 million |
|
PGEN
|
PRECIGEN INC | $1.6 million |
|
NGNE
|
NEUROGENE INC | $1.6 million |
|
BCYC
|
BICYCLE THERAPEUTICS ADR PLC | $1.5 million |
|
CMPS
|
COMPASS PATHWAYS ADR PLC | $1.5 million |
|
AUTL
|
AUTOLUS THERAPEUTICS ADR PLC | $1.5 million |
|
VNDA
|
VANDA PHARMACEUTICALS INC | $1.5 million |
|
MRVI
|
MARAVAI LIFESCIENCES HOLDINGS INC | $1.5 million |
|
TSVT
|
2SEVENTY BIO INC | $1.5 million |
|
IBRX
|
IMMUNITYBIO INC | $1.5 million |
|
ATXS
|
ASTRIA THERAPEUTICS INC | $1.4 million |
|
ERAS
|
ERASCA INC | $1.4 million |
|
GLUE
|
MONTE ROSA THERAPEUTICS INC | $1.4 million |
|
ITOS
|
ITEOS THERAPEUTICS INC | $1.4 million |
|
SLDB
|
SOLID BIOSCIENCES INC | $1.4 million |
|
SANA
|
SANA BIOTECHNOLOGY INC | $1.4 million |
|
ORIC
|
ORIC PHARMACEUTICALS INC | $1.4 million |
|
AVIR
|
ATEA PHARMACEUTICALS INC | $1.4 million |
|
TECX
|
TECTONIC THERAPEUTIC INC | $1.3 million |
|
ALLO
|
ALLOGENE THERAPEUTICS INC | $1.3 million |
|
RAPP
|
RAPPORT THERAPEUTICS INC | $1.2 million |
|
TRDA
|
ENTRADA THERAPEUTICS INC | $1.2 million |
|
QTRX
|
QUANTERIX CORP | $1.2 million |
|
CDXS
|
CODEXIS INC | $1.2 million |
|
TERN
|
TERNS PHARMACEUTICALS INC | $1.2 million |
|
ANNX
|
ANNEXON INC | $1.1 million |
|
IMMP
|
IMMUTEP ADS REPRESENTING LTD | $1.0 million |
|
PSNL
|
PERSONALIS INC | $1.0 million |
|
CRVS
|
CORVUS PHARMACEUTICALS INC | $1.0 million |
|
SLRN
|
ACELYRIN INC | $988865 |
|
PHAT
|
PHATHOM PHARMACEUTICALS INC | $983906 |
|
VYGR
|
VOYAGER THERAPEUTICS INC | $980051 |
|
HUMA
|
HUMACYTE INC | $948651 |
|
IRWD
|
IRONWOOD PHARMA INC CLASS A | $937489 |
|
YMAB
|
Y MABS THERAPEUTICS INC | $917842 |
|
CRGX
|
CARGO THERAPEUTICS INC | $864546 |
|
EDIT
|
EDITAS MEDICINE INC | $859515 |
|
CYBN
|
CYBIN INC | $836965 |
|
FDMT
|
4D MOLECULAR THERAPEUTICS INC | $822645 |
|
FATE
|
FATE THERAPEUTICS INC | $806047 |
|
DSGN
|
DESIGN THERAPEUTICS INC | $792735 |
|
FHTX
|
FOGHORN THERAPEUTICS | $772345 |
|
INBX
|
INHIBRX BIOSCIENCES INC | $764539 |
|
CATX
|
PERSPECTIVE THERAPEUTICS INC | $751961 |
|
ENTA
|
ENANTA PHARMACEUTICALS INC | $698086 |
|
ADCT
|
ADC THERAPEUTICS SA | $681203 |
|
THRD
|
THIRD HARMONIC BIO INC | $680845 |
|
RNAC
|
CARTESIAN THERAPEUTICS INC | $656580 |
|
ALMS
|
ALUMIS INC | $647470 |
|
ACIU
|
AC IMMUNE SA | $644022 |
|
SLN
|
SILENCE THERAPEUTICS ADR REPRESENT | $610452 |
|
MGNX
|
MACROGENICS INC | $607884 |
|
CCCC
|
C4 THERAPEUTICS INC | $579506 |
|
LRMR
|
LARIMAR THERAPEUTICS INC | $574744 |
|
ALEC
|
ALECTOR INC | $566452 |
|
NKTX
|
NKARTA INC | $564196 |
|
PRME
|
PRIME MEDICINE INC | $561226 |
|
LXEO
|
LEXEO THERAPEUTICS INC | $561127 |
|
TNGX
|
TANGO THERAPEUTICS INC | $548290 |
|
PLRX
|
PLIANT THERAPEUTICS INC | $518761 |
|
BMEA
|
BIOMEA FUSION INC | $486696 |
|
TKNO
|
ALPHA TEKNOVA INC | $485904 |
|
CLYM
|
CLIMB BIO INC | $422614 |
|
TCRX
|
TSCAN THERAPEUTICS INC | $405340 |
|
STRO
|
SUTRO BIOPHARMA INC | $398770 |
|
LYEL
|
LYELL IMMUNOPHARMA INC | $345864 |
|
SGAFT
|
CASH COLLATERAL USD SGAFT | $339000 |
|
PYXS
|
PYXIS ONCOLOGY INC | $311336 |
|
PEPG
|
PEPGEN INC | $301614 |
|
KYTX
|
KYVERNA THERAPEUTICS INC | $280612 |
|
NMRA
|
NEUMORA THERAPEUTICS INC | $278201 |
|
ADRO
|
CHINOOK THERAPEUTICS INC | $272817 |
|
APLT
|
APPLIED THERAPEUTICS INC | $253883 |
|
INZY
|
INOZYME PHARMA INC | $244578 |
|
ACRV
|
ACRIVON THERAPEUTICS INC | $214653 |
|
MRSN
|
MERSANA THERAPEUTICS INC | $193062 |
|
ARTV
|
ARTIVA BIOTHERAPEUTICS INC | $177654 |
|
TVGN
|
TEVOGEN BIO HOLDINGS INC | $174817 |
|
OKUR
|
ONKURE THERAPEUTICS INC CLASS A | $143372 |
|
IGMS
|
IGM BIOSCIENCES INC | $132726 |
|
QTTB
|
Q32 BIO INC | $44814 |
|
-
|
CARTESIAN THERAPEUTICS INC | $2998 |
|
-
|
FUSION PHARMACEUTICALS INC CVR | $1034 |
|
-
|
AKOUOS CVRS Prvt | $1 |
|
-
|
OMNIAB INC $15.00 VESTING Prvt | $0 |
|
-
|
OMNIAB INC $12.50 VESTING Prvt | $0 |
|
RTYM5
|
RUSSELL 2000 EMINI CME JUN 25 | $0 |
|
IXCM5
|
E-MINI HEALTH CARE SECTOR JUN 25 | $0 |
|
USD
|
USD CASH | $-1.2 million |
Recent Changes - iShares Biotechnology ETF
| Date | Ticker | Name | Change (Shares) |
|---|---|---|---|
| 2025-04-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-04-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-04-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-23 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-22 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-16 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-04-11 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-04-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-09 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-04-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-04-08 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-07 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-04 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-04-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-04-03 |
ITCI
|
INTRA CELLULAR THERAPIES INC | -632,015 |
| 2025-04-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-02 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-01 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-01 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-31 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-03-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-03-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-26 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-03-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-03-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-20 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-19 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-19 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-18 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-17 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-03-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-03-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-13 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-12 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-03-11 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-03-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-03-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-07 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-03-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-06 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-03-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-05 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-26 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-20 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-19 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-19 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-18 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-13 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-12 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-11 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-07 |
USD
|
USD CASH | 0 |
| 2025-02-07 |
USD
|
USD CASH | None |
| 2025-02-07 |
SGAFT
|
CASH COLLATERAL USD SGAFT | None |
| 2025-02-07 |
SGAFT
|
CASH COLLATERAL USD SGAFT | 0 |
| 2025-02-06 |
RVNC
|
REVANCE THERAPEUTICS INC | None |
| 2025-02-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-05 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-04 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-03 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-03 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-31 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-30 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-29 |
OKUR
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-29 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-23 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-22 |
OKUR
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-22 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-16 |
NBTX
|
NANOBIOTIX ADR REPRESENTING SA | None |
| 2025-01-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-13 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-09 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-09 |
ORKA
|
Oruka Therapeutics Inc | -191,766 |
| 2025-01-09 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2025-01-09 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -61,675 |
| 2025-01-09 |
OKUR
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-08 |
ORKA
|
Oruka Therapeutics Inc | -191,766 |
| 2025-01-08 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -61,675 |
| 2025-01-08 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2025-01-08 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-08 |
OKUR
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-07 |
PSTX
|
POSEIDA THERAPEUTICS INC | None |
| 2025-01-06 |
RPHM
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-06 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-06 |
ORKA
|
Oruka Therapeutics Inc | -195,585 |
| 2025-01-06 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -62,910 |
| 2025-01-06 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2025-01-03 |
NAUT
|
NAUTILUS BIOTECHNOLGY INC | None |
| 2025-01-02 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2025-01-02 |
RPHM
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-02 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-02 |
ORKA
|
Oruka Therapeutics Inc | -194,781 |
| 2025-01-02 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -62,650 |
| 2025-01-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2024-12-31 |
CYBN.NE
|
Cybin Inc Ordinary Shares | -121,241 |
| 2024-12-31 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2024-12-31 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2024-12-31 |
ORKA
|
Oruka Therapeutics Inc | -196,188 |
| 2024-12-31 |
CYBN.NE
|
CYBIN INC | None |
| 2024-12-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2024-12-30 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -62,845 |
| 2024-12-30 |
RPHM
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2024-12-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2024-12-30 |
ORKA
|
Oruka Therapeutics Inc | -195,384 |
| 2024-12-30 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2024-12-30 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2024-12-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2024-12-27 |
RPHM
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2024-12-27 |
ORKA
|
Oruka Therapeutics Inc | 195,384 |
| 2024-12-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2024-12-27 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | 62,845 |
| 2024-12-27 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2024-12-26 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -63,365 |
| 2024-12-26 |
ORKA
|
Oruka Therapeutics Inc | -194,705 |
| 2024-12-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2024-12-26 |
RPHM
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2024-12-26 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2024-12-26 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2024-12-24 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2024-12-24 |
RPHM
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2024-12-24 |
MRNS
|
Marinus Pharmaceuticals Inc | -20,592 |
| 2024-12-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2024-12-24 |
OVID
|
Ovid Therapeutics Inc | -2,611 |
| 2024-12-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2024-12-24 |
ORKA
|
Oruka Therapeutics Inc | -180,749 |
| 2024-12-24 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -63,365 |
| 2024-12-20 |
ALT
|
Altimmune Inc | 458,144 |
| 2024-12-20 |
AVBP
|
ArriVent BioPharma Inc | 126,331 |
| 2024-12-20 |
ANNX
|
Annexon Inc Ordinary Shares | 580,213 |
| 2024-12-20 |
CCCC
|
C4 Therapeutics Inc Ordinary Shares | 368,099 |
| 2024-12-20 |
ATXS
|
Astria Therapeutics Inc | 313,433 |
| 2024-12-20 |
DSGN
|
Design Therapeutics Inc | 204,003 |
| 2024-12-20 |
TYRA
|
Tyra Biosciences Inc | 183,959 |
| 2024-12-20 |
NAMS
|
NewAmsterdam Pharma Co NV | 278,749 |
| 2024-12-20 |
EVO
|
Evotec SE ADR | 1.4 million |